Trademarks

Aliveg: drug also developed with Smith Kline French. It is based on cimetidine just in different proportions, the active ingredient (cimetidine) and excipient (sodium bicarbonate). It was designed and introduced to the market in Spain Nicolas Villen, international vice president at the time of the laboratory. It is for minor annoyances, and used 200 mg per day. Tagamet: cimetidine trademark, the name was devised by the discoverer laboratory (Smith Kline French). There are products on the market sold in Spain under other names, as in Spain, unlike other countries, legislation allows the marketing of generic products using the INN (International Nonproprietary Name) of the substance by laboratories that are not the owner of the patent.